Literature DB >> 1313449

Preferential mRNA expression of prostromelysin relative to procollagenase and in situ localization in human articular cartilage.

Q Nguyen1, J S Mort, P J Roughley.   

Abstract

An imbalance between extracellular proteinases and their inhibitors is thought to underlie cartilage degradation. In cultures of adult cartilage, prostromelysin mRNA levels were much higher than those for procollagenase and this differential was increased in cultures stimulated with IL-1 beta. Analysis of mRNA prepared from freshly isolated chondrocytes showed abundant amounts of prostromelysin mRNA in normal adult cartilage but low levels in the neonate. Not all adult cartilage may possess such high levels of prostromelysin mRNA, as the message levels in the cartilage remaining on late-stage osteoarthritic joints were lower than those in normal adult cartilage. Relative to prostromelysin mRNA, little procollagenase and TIMP mRNA were found in the adult cartilage. In situ hybridization revealed that metalloproteinase mRNAs were localized in chondrocytes of the superficial zone in adult cartilage. However, upon IL-1 beta treatment, chondrocytes in all cartilage zones were observed to express prostromelysin mRNA. Relative to the neonate, the normal adult cartilage appears to have a high degradative potential, if one accepts that steady-state mRNA levels reflect prostromelysin production. As the adult cartilage is not apparently undergoing rapid turnover, it would appear that control of prostromelysin activation may be the major regulatory step in stromelysin-induced cartilage degradation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1313449      PMCID: PMC442978          DOI: 10.1172/JCI115702

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Comparison of human stromelysin and collagenase by cloning and sequence analysis.

Authors:  S E Whitham; G Murphy; P Angel; H J Rahmsdorf; B J Smith; A Lyons; T J Harris; J J Reynolds; P Herrlich; A J Docherty
Journal:  Biochem J       Date:  1986-12-15       Impact factor: 3.857

2.  Type X collagen contains two cleavage sites for a vertebrate collagenase.

Authors:  T M Schmid; R Mayne; J J Jeffrey; T F Linsenmayer
Journal:  J Biol Chem       Date:  1986-03-25       Impact factor: 5.157

3.  Characterization of a specific antiserum to rabbit stromelysin and demonstration of the synthesis of collagenase and stromelysin by stimulated rabbit articular chondrocytes.

Authors:  G Murphy; R M Hembry; J J Reynolds
Journal:  Coll Relat Res       Date:  1986-10

4.  Purification and characterization of collagenase activator protein synthesized by articular cartilage.

Authors:  B V Treadwell; J Neidel; M Pavia; C A Towle; M E Trice; H J Mankin
Journal:  Arch Biochem Biophys       Date:  1986-12       Impact factor: 4.013

5.  Degradation of type IX collagen by matrix metalloproteinase 3 (stromelysin) from human rheumatoid synovial cells.

Authors:  Y Okada; H Konomi; T Yada; K Kimata; H Nagase
Journal:  FEBS Lett       Date:  1989-02-27       Impact factor: 4.124

6.  Stimulation of procollagenase synthesis parallels increases in cellular procollagenase mRNA in human articular chondrocytes exposed to recombinant interleukin 1 beta or phorbol ester.

Authors:  M L Stephenson; M B Goldring; J R Birkhead; S M Krane; H J Rahmsdorf; P Angel
Journal:  Biochem Biophys Res Commun       Date:  1987-04-29       Impact factor: 3.575

7.  Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene.

Authors:  J Y Tso; X H Sun; T H Kao; K S Reece; R Wu
Journal:  Nucleic Acids Res       Date:  1985-04-11       Impact factor: 16.971

8.  Primary structure and cDNA cloning of human fibroblast collagenase inhibitor.

Authors:  D F Carmichael; A Sommer; R C Thompson; D C Anderson; C G Smith; H G Welgus; G P Stricklin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

9.  Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase. Biosynthesis, isolation, characterization, and substrates.

Authors:  J R Chin; G Murphy; Z Werb
Journal:  J Biol Chem       Date:  1985-10-05       Impact factor: 5.157

10.  Collagenase at sites of cartilage erosion in the rheumatoid joint.

Authors:  D E Woolley; M J Crossley; J M Evanson
Journal:  Arthritis Rheum       Date:  1977 Jul-Aug
View more
  15 in total

1.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis.

Authors:  Y Yoshihara; H Nakamura; K Obata; H Yamada; T Hayakawa; K Fujikawa; Y Okada
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

2.  Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.

Authors:  M W Lark; E K Bayne; J Flanagan; C F Harper; L A Hoerrner; N I Hutchinson; I I Singer; S A Donatelli; J R Weidner; H R Williams; R A Mumford; L S Lohmander
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

3.  Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte.

Authors:  I G Charles; R M Palmer; M S Hickery; M T Bayliss; A P Chubb; V S Hall; D W Moss; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

4.  Quantification of mRNA levels in joint capsule and articular cartilage of the murine knee joint by RT-PCR: kinetics of stromelysin and IL-1 mRNA levels during arthritis.

Authors:  J B Van Meurs; P L Van Lent; L A Joosten; P M Van der Kraan; W B Van den Berg
Journal:  Rheumatol Int       Date:  1997       Impact factor: 2.631

5.  Increased expression of matrix metalloproteinases in vivo in scleritis tissue and in vitro in cultured human scleral fibroblasts.

Authors:  N Di Girolamo; A Lloyd; P McCluskey; M Filipic; D Wakefield
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

6.  The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis.

Authors:  P Reboul; J P Pelletier; G Tardif; J M Cloutier; J Martel-Pelletier
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

7.  Gene expression of matrix metalloproteinases 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific.

Authors:  A J Freemont; V Hampson; R Tilman; P Goupille; Y Taiwo; J A Hoyland
Journal:  Ann Rheum Dis       Date:  1997-09       Impact factor: 19.103

8.  Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration.

Authors:  A P Hollander; I Pidoux; A Reiner; C Rorabeck; R Bourne; A R Poole
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

9.  The mechanism of aggrecan release from cartilage differs with tissue origin and the agent used to stimulate catabolism.

Authors:  Robert Sztrolovics; Robert J White; Peter J Roughley; John S Mort
Journal:  Biochem J       Date:  2002-03-01       Impact factor: 3.857

10.  Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein.

Authors:  Q Nguyen; G Murphy; C E Hughes; J S Mort; P J Roughley
Journal:  Biochem J       Date:  1993-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.